ARTICLE | Clinical News
Velcade bortezomib regulatory update
October 4, 2004 7:00 AM UTC
MLNM submitted an sNDA to FDA for Velcade bortezomib, a small molecule dipeptide boronic acid proteasome inhibitor, to treat multiple myeloma (MM) in patients who have received at least one prior ther...